Occult retinopathy following treatment of Hepatitis C with glecaprevir/pibrentasvir (Mavyret)

Massengill, Michael; Park, Jason C; McAnany, J. Jason; Hyde, Robert A.

doi:10.1007/s10633-023-09923-0

Search citation statements

Order By: Relevance

Paper Sections

Select...

Overview Of the Viral Diseases1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2023

2024

Publication Types

Select...

Article3

Book1

Relationship

Self Cite0

Independent4

Authors

Journals

Cited by 4 publications

(1 citation statement)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Mavyret, which is the composition of glecaprevir and pibrentasvir, was the best-selling anti-HCV drug in 2018 [ 51 ]. Asunaprevir, boceprevir and grazoprevir inhibit the proteolytic activity of HCV NS3/4A protease and show promising anti-HCV properties [ 52 , 53 , 54 ].…”

Section: Overview Of the Viral Diseasesmentioning

confidence: 99%

Structural and Synthetic Aspects of Small Ring Oxa- and Aza-Heterocyclic Ring Systems as Antiviral Activities

Manna,

Das,

Santra

et al. 2023

Viruses

View full text Add to dashboard Cite

Antiviral properties of different oxa- and aza-heterocycles are identified and properly correlated with their structural features and discussed in this review article. The primary objective is to explore the activity of such ring systems as antiviral agents, as well as their synthetic routes and biological significance. Eventually, the structure–activity relationship (SAR) of the heterocyclic compounds, along with their salient characteristics are exhibited to build a suitable platform for medicinal chemists and biotechnologists. The synergistic conclusions are extremely important for the introduction of a newer tool for the future drug discovery program.

show abstract

Section: Overview Of the Viral Diseasesmentioning

confidence: 99%